InvestSMART

Alcidion Group Limited (ASX: ALC) - Announcements

Current share price for ALC : $0.095 0.003 (3.06%)+

ASX company news and announcements for Alcidion Group Limited (ALC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Alcidion Group Limited (ALC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Alcidion Group Limited (ALC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Alcidion Group Limited (ALC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$128 Becoming a substantial holder 4 Jul 2018 8:27AM $0.053 $0.095 risen by 79.25%
$128 Initial Director's Interest Notice - Kate Quirke 3 Jul 2018 4:20PM $0.053 $0.095 risen by 79.25%
$128 Appendix 3B 3 Jul 2018 4:20PM $0.053 $0.095 risen by 79.25%
$128 Alcidion completes acquisition of MKM/Patientrack 3 Jul 2018 4:20PM $0.053 $0.095 risen by 79.25%
$128 Alcidion EGM Results of Meeting 14 Jun 2018 1:21PM $0.057 $0.095 risen by 66.67%
$128 Alcidion EGM Chairman's Address 14 Jun 2018 1:20PM $0.057 $0.095 risen by 66.67%
$128 Alcidion to present at Tech 121 Conference in Hong Kong 13 Jun 2018 9:47AM $0.054 $0.095 risen by 75.93%
$128 Alcidion - MKM Health signs major contract with eHealth NSW 12 Jun 2018 10:07AM $0.049 $0.095 risen by 93.88%
$128 Alcidion - Patientrack contract wins 16 May 2018 10:05AM $0.047 $0.095 risen by 102.13%
$128 Notice of Extraordinary General Meeting/Proxy Form 15 May 2018 8:22AM $0.048 $0.095 risen by 97.92%
$128 Change of Director's Interest Notice 8 May 2018 3:34PM $0.047 $0.095 risen by 102.13%
$128 Alcidion to present at Investor Roadshow 2 May 2018 8:19AM $0.045 $0.095 risen by 111.11%
$128 Change of Director's Interest Notice 1 May 2018 11:37AM $0.040 $0.095 risen by 137.50%
$128 Alcidion to acquire MKM Health and Patientrack 24 Apr 2018 8:24AM $0.036 $0.095 risen by 163.89%
$128 Alcidion Appendix 4C - Correction 23 Apr 2018 1:51PM $0.034 $0.095 risen by 179.41%
$128 Alcidion Appendix 4C - Quarterly 23 Apr 2018 1:08PM $0.037 $0.095 risen by 156.76%
$128 Alcidion Smartpage goes live at Monash Health 26 Mar 2018 11:00AM $0.040 $0.095 risen by 137.50%
$128 Appendix 3B 8 Mar 2018 4:46PM $0.044 $0.095 risen by 115.91%
$128 Alcidion to present at ASX Breakfast Event 6 Mar 2018 5:10PM $0.039 $0.095 risen by 143.59%
$128 Alcidion Half Year Report and Appendix 4D 27 Feb 2018 12:09PM $0.043 $0.095 risen by 120.93%
$128 Alcidion to Release securities from escrow 14 Feb 2018 12:48PM $0.046 $0.095 risen by 106.52%
$128 Alcidion Completes Acquisition of Oncall 2 Feb 2018 3:58PM $0.045 $0.095 risen by 111.11%
$128 Alcidion Appendix 4C - quarterly 31 Jan 2018 1:50PM $0.050 $0.095 risen by 90%
$128 Smartpage Orderly goes live at major New Zealand hospital 10 Jan 2018 10:42AM $0.047 $0.095 risen by 102.13%
$128 Alcidion appoints industry veteran Kevin Moynihan 14 Dec 2017 11:01AM $0.050 $0.095 risen by 90%

451 - 475 of 589 results

Page 19 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.